# Prospective Tumor Response Evaluation

> **NCT02787954** · — · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 10 (actual)

## Conditions studied

- Hepatocellular Cancer
- Metastatic Liver Cancer

## Interventions

- **PROCEDURE:** TACE
- **PROCEDURE:** Y-90
- **PROCEDURE:** MWA
- **PROCEDURE:** IRE

## Key facts

- **NCT ID:** NCT02787954
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** PI transferred to another institution and did not take this study with him.
- **Last updated:** 2018-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787954, "Prospective Tumor Response Evaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02787954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*